Cite Filings / ORIC / 0001193125-21-130074

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Oric Pharmaceuticals, Inc. Filed 2021-04-26 Acc 0001193125-21-130074

Documents 1

DEF 14A Proxy Statement , d127916ddef14a.htm

Around this filing

2022-04-27 DEF 14A Proxy Statement
2021-04-30 4 Director sold 200 shares at an average $25.17 ($5,034)
2021-04-30 4 Director sold 300 shares at an average $25.14 ($7,541)
2021-04-30 4 President and CEO sold 1,300 shares at an average $25.14 ($32,685)
2021-04-26 DEFA14A Proxy Materials
2021-04-26 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d127916ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…